Andrew's been talking to experts to get a better idea of how to interpret the late-stage vaccine data when it starts showing up. As part of that, he asked the experts what they'd want to see in the data before they'd get a vaccine themselves, and when they'd feel comfortable taking a shot.
GoodRx raised $1.6 billion in the IPO, and as of Friday, the stock's trading at just under $50 a share, up from the $33 share price it set before its first day of trading.
Amazon this week expanded out its Amazon Care service to employees in Washington state. (Previously, the pilot was just available to employees in the Seattle area.)
Blake spoke with Erik Cardenas, one of the tech leads for Amazon Care. His job is to coordinate all kinds of patient information into a seamless system.
He shared with Blake how he got to be a key part of Amazon's push into healthcare.
Biden would face a lot of distrust, and a smooth transition between administrations isn't a sure thing. What's definitely in the cards: Dr. Anthony Fauci would stick around.
I caught up with Bright's chief financial officer Cathy Smith on Tuesday, who told me the most recent round — with its crossover investors — would suggest that the next logical step is an IPO. When that'll happen remains to be seen.
"The business will tell us when it's ready," Smith told me.
With that, I'll leave you to your weekends. I'll be kicking off mine by getting a flu shot — consider this my compulsory healthcare-editor reminder to get yours as well!
NewsletterSIMPLY PUT - where we join the dots to inform and inspire you. Sign up for a weekly brief collating many news items into one untangled thought delivered straight to your mailbox.